{"id":"W2252494760","doi":"10.1200/jco.2006.24.18_suppl.10565","title":"Adjuvant trastuzumab (T) therapy in HER2+ breast cancer after ASCO 2005: Patients’ attitudes and immediate economic burden","year":2006,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"","keywords":"Medicine; Adjuvant; Trastuzumab; Breast cancer; Adjuvant therapy; Internal medicine; Cancer; Disease; Clinical trial; Oncology; Chemotherapy; Medical record; Adjuvant chemotherapy; Gynecology; Family medicine","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002326835,0.00009864064,0.0002194864,0.0005091953,0.0006170824,0.001051506,0.0002052618,0.0003355168,0.00233195],"category_scores_gemma":[0.009231717,0.00009145535,0.0002298041,0.0009861571,0.0003994234,0.0006447933,0.0005276552,0.0004524256,0.0001865547],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008678024,"about_ca_system_score_gemma":0.0006164479,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002759086,"about_ca_topic_score_gemma":0.004855318,"domain_scores_codex":[0.9985628,0.0008559187,0.0001062168,0.00005970861,0.000231173,0.0001843341],"domain_scores_gemma":[0.9928766,0.003042829,0.002989395,0.0001253862,0.0001970439,0.0007686411],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0007971177,0.000172252,0.9715621,0.00004454748,0.00004064939,0.0004242244,0.0005679323,0.0001873074,0.0001266694,0.0001582746,0.002232622,0.02368624],"study_design_scores_gemma":[0.0001100469,0.0008314375,0.9930423,0.00008830009,0.00005295265,0.0009214085,0.00147575,0.0008583281,0.0001337302,0.0002356657,0.00223688,0.00001312724],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9960466,0.0007875413,0.00002710137,0.001308416,0.000009887207,0.00001270039,0.00008759994,0.000001401585,0.001718786],"genre_scores_gemma":[0.9988525,0.0004842996,0.00004280053,0.0003740358,0.00003112721,0.000006802592,0.00005978919,7.536734e-7,0.0001479418],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002759086,"threshold_uncertainty_score":0.01230562,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0655376748397551,"score_gpt":0.4714635732115428,"score_spread":0.4059258983717877,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}